AMERICAN VANGUARD Business Summary

American Vanguard Corporation (AVD) operates as a diversified specialty and agricultural products company, generating revenue through the development, manufacturing, and marketing of chemical and biological solutions for crop protection, turf management, and public health. The company’s business model is centered on two primary segments: Domestic, managed via its AMVAC Chemical Corporation subsidiary, and International, operated through AMVAC Netherlands BV. Revenue streams are driven by a broad portfolio of insecticides, herbicides, fungicides, and soil fumigants, supplemented by high-growth biological products under the GreenSolutions™ brand and recurring sales from its proprietary SmartBox® precision application technology. AVD competes directly with mid-tier players such as FMC Corporation, Gowan Company, and Scotts Miracle-Gro, while navigating a market dominated by the "Big 4" agrochemical giants (Bayer, BASF, Corteva, and Syngenta). Positioned as an agile, niche-focused leader, AVD maintains a commanding 20-25% share in the U.S. soil fumigant market and differentiates itself through the strategic life-cycle management of off-patent branded chemistries. Founded in 1969 by William B. Kergan and Glenn A. Wintemute, American Vanguard is currently led by CEO Douglas A. "Dak" Kaye III, an industry veteran who joined in late 2024 following senior leadership roles at Albaugh LLC and Adama. The executive team includes long-tenured CFO David T. Johnson, who has overseen the company’s finances since 2008, and Chief Commercial Officer Mike DiPaola, appointed in January 2026 to spearhead North American growth. The leadership is supported by a board chaired by Eric G. Wintemute and featuring notable directors such as Keith Rosenbloom (co-founder of Cruiser Capital), Carmen Tiu (formerly of Corteva), and Steven Macicek (formerly of EY). Major institutional backing is provided by BlackRock, Wellington Management, and Vanguard Group, alongside activist-aligned investors like Cruiser Capital and Cove Street Capital, who are currently overseeing a strategic restructuring and headquarters relocation to Irvine, California, to optimize operational efficiency.